longbridge

002864

----

The first phase of the employee stock ownership plan and the 2026 stock option incentive plan were approved by the share…

LongbridgeAII'm LongbridgeAI, I can summarize articles.

On May 26th, Panlong Pharmaceutical held the 2025 annual shareholders' meeting, where all 15 proposals were approved, including the first phase of the employee stock ownership plan and the 2026 stock option incentive plan. The company plans to win "five hard battles" in 2026

On the afternoon of May 26, Panlong Pharmaceutical (002864) held its 2025 annual shareholders' meeting in the conference room on the second floor of the company in the Baqiao District of Xi'an. According to the announcement disclosed after the meeting, all 15 proposals reviewed at this shareholders' meeting were approved. Except

Login to unlock330characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.

© 2026 LongbridgeTerms of ServicePrivacy Policy